| 1 |
35570320 | Treatment of MDA5-positive dermatomyositis complicated by gangrenous cholecystitis with tofacitinib. | 2022 May 15 |
3 |
| 2 |
30614890 | Successful Treatment for Refractory Interstitial Lung Disease and Pneumomediastinum With Multidisciplinary Therapy Including Tofacitinib in a Patient With Anti-MDA5 Antibody-Positive Dermatomyositis. | 2021 Dec 1 |
1 |
| 3 |
32867615 | Successful dose escalation of tofacitinib for refractory dermatomyositis and interstitial lung disease with anti-melanoma differentiation-associated gene 5 antibodies. | 2021 Jan |
3 |
| 4 |
33252394 | A Case of Refractory Interstitial Lung Disease in Anti-MDA5-Positive Dermatomyositis That Improved After Switching to Tofacitinib. | 2021 Dec 1 |
1 |
| 5 |
33769925 | Tofacitinib in interstitial lung disease complicated with anti-MDA5 antibody-positive dermatomyositis: A literature review. | 2021 Apr 15 |
1 |
| 6 |
34946303 | Combination Therapy with Rituximab, Tofacitinib and Pirfenidone in a Patient with Rapid Progressive Interstitial Lung Disease (RP-ILD) Due to MDA5 Antibody-Associated Dermatomyositis: A Case Report. | 2021 Dec 13 |
2 |
| 7 |
32360518 | Efficacy of tofacitinib for slowly progressive interstitial lung disease in a patient with anti-MDA5 antibody-positive dermatomyositis. | 2020 Jun |
1 |
| 8 |
32925726 | Tofacitinib for recurrence of antimelanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis after remission: A case report. | 2020 Sep 11 |
2 |
| 9 |
31603183 | Reply: Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib. | 2019 Nov 1 |
1 |
| 10 |
31603187 | Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib. | 2019 Nov 1 |
1 |
| 11 |
30060040 | Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis. | 2018 Dec 1 |
1 |